Gabriel M. Morin
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Radiological evaluation of the natural history of PIK3CA-related overgrowth spectrum (PROS).
Journal: European journal of radiology
Published: June 12, 2026
PIK3CA gain-of-function mutation in Schwann cells leads to severe neuropathy and aerobic glycolysis through a non-cell autonomous effect.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 24, 2025
Vascular malformations: from genetics to therapeutics.
Journal: EMBO molecular medicine
Published: March 12, 2025
Drug repurposing in PIK3CA-related overgrowth spectrum: breakthroughs from overgrowth syndromes to kidney disease.
Journal: Kidney international
Published: February 14, 2025
First report of successful pregnancies after treatment with alpelisib for PIK3CA-related overgrowth spectrum.
Journal: European journal of human genetics : EJHG
Published: January 22, 2025
Sotorasib for Vascular Malformations Associated with KRAS G12C Mutation.
Journal: The New England journal of medicine
Published: July 17, 2024
PIK3CA-Related Disorders: From Disease Mechanism to Evidence-Based Treatments.
Journal: Annual review of genomics and human genetics
Published: February 05, 2024
Somatic PIK3R1 mutations in the iSH2 domain are accessible to PI3Kα inhibition.
Journal: EMBO molecular medicine
Published: October 03, 2023
PIK3CA gain-of-function mutation in adipose tissue induces metabolic reprogramming with Warburg-like effect and severe endocrine disruption.
Journal: Science advances
Published: December 09, 2022
Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib.
Journal: The Journal of experimental medicine
Published: October 18, 2021
Alpelisib administration reduced lymphatic malformations in a mouse model and in patients.
Journal: Science translational medicine
Published: October 06, 2021
Treatment strategies for mosaic overgrowth syndromes of the PI3K-AKT-mTOR pathway.
Journal: British medical bulletin
Published: April 13, 2021
Last Updated: 09/26/2026